doi: 10.1111/j.1365-2133.2006.07211.x.
Elevated circulating CD40 ligand in patients with erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum
- PMID: 16634916
- DOI: 10.1111/j.1365-2133.2006.07211.x
Item in Clipboard
Elevated circulating CD40 ligand in patients with erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum
Br J Dermatol.
2006 May.
No abstract available
Similar articles
-
The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.Br J Dermatol. 2006 Feb;154(2):319-24. doi: 10.1111/j.1365-2133.2005.07023.x. Br J Dermatol. 2006. PMID: 16433803
-
Serum interleukin-13 levels are increased in patients with Stevens-Johnson syndrome/ toxic epidermal necrolysis but not in those with erythema multiforme.Br J Dermatol. 2008 Jan;158(1):184-6. doi: 10.1111/j.1365-2133.2007.08259.x. Epub 2007 Oct 17. Br J Dermatol. 2008. PMID: 17941938 No abstract available.
-
Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.Dermatology. 2007;214(4):296-304. doi: 10.1159/000100880. Dermatology. 2007. PMID: 17460400
-
Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.Dermatol Clin. 1992 Jul;10(3):571-82. Dermatol Clin. 1992. PMID: 1617814 Review.
-
[Erythema multiforme exudativum, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell's syndrome) and their interrelationship].Vestn Dermatol Venerol. 1980 Mar;(3):36-42. Vestn Dermatol Venerol. 1980. PMID: 6990649 Review. Russian. No abstract available.
Cited by
-
Toxic Epidermal Necrolysis - A Case Report.J Crit Care Med (Targu Mures). 2017 Feb 18;3(1):29-33. doi: 10.1515/jccm-2017-0002. eCollection 2017 Feb. J Crit Care Med (Targu Mures). 2017. PMID: 29967868 Free PMC article.
-
Management of Stevens-Johnson Syndrome-Toxic Epidermal Necrolysis: Looking Beyond Guidelines!Indian J Dermatol. 2018 Mar-Apr;63(2):117-124. doi: 10.4103/ijd.IJD_583_17. Indian J Dermatol. 2018. PMID: 29692452 Free PMC article.
-
In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology.Br J Clin Pharmacol. 2015 Oct;80(4):889-900. doi: 10.1111/bcp.12505. Epub 2015 Jun 1. Br J Clin Pharmacol. 2015. PMID: 25199801 Free PMC article. Review.
-
Clinical features, outcomes and treatment in children with drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis.Acta Biomed. 2019 Jan 29;90(3-S):52-60. doi: 10.23750/abm.v90i3-S.8165. Acta Biomed. 2019. PMID: 30830062 Free PMC article. Review.
-
Stevens-Johnson syndrome/toxic epidermal necrolysis induced by lamotrigine in a patient with a cerebral cavernous malformation: a case report.Dermatol Reports. 2025 May 23;17(2):10007. doi: 10.4081/dr.2024.10007. Epub 2024 Dec 10. Dermatol Reports. 2025. PMID: 39969071 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
